9-(β-D-Xylofuranosyl)adenine

524-69-6

CAS-Nr.: 524-69-6

Englisch Name:: 9-(β-D-Xylofuranosyl)adenine

Synonyma:: Xa;Nsc7359;Nsc 7359;Xylosyl a;Xylosyladenine;Xylo-adenosine;Adenine xyloside;Xylo-adenosine, NSC7359;9-(-D-Xylofuranosyl)adenine;9-(b-D-Xylofuranosyl)adenine

CBNumber:: CB61456378

Summenformel:: C10H13N5O4

Molgewicht:: 267.24

MOL-Datei:: 524-69-6.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 17

9-(β-D-Xylofuranosyl)adenine Eigenschaften

Schmelzpunkt:: 125-140 °C

Siedepunkt:: 676.3±65.0 °C(Predicted)

Dichte: 2.08±0.1 g/cm3(Predicted)

pka: 13.11±0.70(Predicted)

Aggregatzustand: Solid

Farbe: White to off-white

InChI: InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)

InChIKey: OIRDTQYFTABQOQ-UHFFFAOYSA-N

SMILES: O1C(CO)C(O)C(O)C1N1C2=C(N=C1)C(N)=NC=N2

Sicherheit

9-(β-D-Xylofuranosyl)adenine Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

9-(β-d-Xylofuranosyl)adenine (xylo-A) was synthesized long ago and found to be effective in prolonging the survival time of mice bearing TA3 or Ehrlich ascites tumours. It is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. 9-(β-d-Arabinofuranosyl)adenine (vidarabine), which was reported to have similar antitumour properties to xylo-A, is now being used clinically as an antiviral agent[1].

Definition

ChEBI: A purine nucleoside in which adenine is attached to xylofuranose via a beta-N9-glycosidic bond.

9-(β-D-Xylofuranosyl)adenine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

9-(β-D-Xylofuranosyl)adenine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 17)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD	0371-55159968 18137130222	haifeng.zhang@pannacean.com	China	512	58
Shenzhen Nexconn Pharmatechs Ltd	+86-755-89396905 +86-15013857715	admin@nexconn.com	China	10311	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.	+86-021-61551413 +8618813727289	contact@trustwe.com	China	5738	58
NewCan Biotech Limited	+86-0571-86912261 +8613735419629	sales@newcanbio.com	China	9980	58
LEAPCHEM CO., LTD.	+86-852-30606658	market18@leapchem.com	China	43348	58
Wuhan Fortuna Chemical Co.,Ltd	+8618007136271	hk@fortunachem.com	China	5986	58
Nanjing Baifuli Technology Co., Ltd.	25-25-58740604 15951658055	sales@unisyn.cn	China	561	58
Fuyang Ziyi Biological Pharmaceutical Co., Ltd.	19308655899	2677609105@qq.com	China	464	58
Zhengzhou Granlen Sciences, ltd.	0371-85513397	info@granlen.com	China	1842	58

9-.beta.-D-Xylofuranosyladenine
9H-Purin-6-amine, 9-.beta.-D-xylofuranosyl-
Adenine xyloside
Adenine, 9-.beta.-D-xylofuranosyl-
Nsc 7359
Nsc7359
Xa
Xylosyl a
Xylosyladenine
9-(-D-Xylofuranosyl)adenine
9H-Purin-6-amine, 9-β-D-xylofuranosyl-
Xylo-adenosine
9-(b-D-Xylofuranosyl)adenine
9-(b-D-Xylofuranosyl)adenine,Xylo-adenosine, anticancer agent
Xylo-adenosine, NSC7359
9-(?-D-Xylofuranosyl) adenine Xylo-adenosine
9-(β-D-Xylofuranosyl)adenine
Xylosyladenine|||Adenine xyloside
524-69-6
524-69-2